Kidney Res Clin Pract > Volume 38(4); 2019 > Article |
|
Authors’ contributions
Jung-Hwa Ryu, Kil-Yong Lee, and Tai Yeon Koo participated in data collection and manuscript writing. Kook-Hwan Oh, Jaeseok Yang, and Kyu Joo Park participated in study design and data analysis and interpretation. Dong Ki Kim participated in the critical review of the study design and manuscript. All authors have read and approved the final manuscript.
Patients | Age (yr) | Sex | Underlying renal disease | PD duration (yr) | Reason for PD discontinuation | Peritonitis episode number | Onset of EPS from PD withdrawal (mo)a | Clinical symptoms |
---|---|---|---|---|---|---|---|---|
1 | 48 | Female | Hypertension | 6 | Peritonitis | 1 | 1 | P, F |
2 | 42 | Male | IgA nephropathy | 21 | Peritonitis | 2 | 1 | N, V, P |
3 | 54 | Female | Unknown | 6 | Peritonitis | 3 | 156 | N, V, P |
4 | 63 | Male | Hypertension | 11 | Peritonitis | 2 | −21a | N, V, P, F |
5 | 51 | Male | Unknown | 18 | EPS | 5 | −1a | N, V, P |
6 | 54 | Male | HBGN | 16 | KT | 1 | 48 | N, V, P, F |
7 | 48 | Female | GN | 12 | KT | > 1 | 18 | N, V, P, F, C |
8 | 50 | Male | Trauma | 16 | EPS | 0 | 2 | N/abdominal fullness |
9 | 43 | Female | Hypertension | 7 | Peritonitis | > 1 | 36 | N, V, P |
10 | 42 | Male | ADPKD | 11 | EPS | 1 | −11a | N, V |
11 | 38 | Male | GN | 10 | KT | 0 | −3a | N, V, P, F |
12 | 58 | Male | Unknown | 8 | EPS | 0 | 2 | A, N, F |
13 | 29 | Male | FSGS | 9 | Peritonitis | 7 | 20 | N, P |
ADPKD, autosomal dominant polycystic kidney disease; C, constipation; EPS, encapsulating peritoneal sclerosis; F, fever; FSGS, focal segment glomerulosclerosis; GN, glomerulonephritis; HBGN, hepatitis B-associated glomerulonephritis; KT, kidney transplantation; N, nausea; P, pain; PD, peritoneal dialysis; V, vomiting.
Patients | BMI (kg/m2) | Ab (g/dL) | Hb (g/dL) | hs-CRPa (mg/dL) (hs-CRPb) | Ca (mg/dL) | P (mg/dL) | CT scan score | Pre-EPS CT score (moc) | Organisms at peritonitisd | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||
Peritoneal thickening | Bowel wall thickening | Bowel tethering | Bowel dilatation | Loculation | Peritoneal calcification | Total score | |||||||||
1 | 19.0 | 3.6 | 11.8 | 26.35 (1.28) | 8.2 | 8.3 | 4 | 2 | 0 | 3 | 0 | 2 | 11 | 4 (12) | Escherichia coli, Clostridium species |
2 | 19.9 | 3.0 | 10.4 | 2.40 (1.81) | 10.5 | 4.2 | 4 | 4 | 1 | 3 | 3 | 2 | 17 | 14 (11) | Enterococcus faecium, Staphylococcus xylosus, Pseudomonas fluorescens |
3 | 22.9 | 2.7 | 10.9 | 1.70 (1.05) | 9.9 | 4.5 | 3 | 3 | 2 | 4 | 2 | 1 | 15 | 12 (5) | E. coli, unknown, Candida glabrata |
4 | 22.6 | 2.9 | 8.9 | 12.9 (0.4) | 10.1 | 3.5 | 3 | 4 | 1 | 3 | 2 | 4 | 17 | 10 (23) | E. faecium, E. coli |
5 | 18.0 | 3.6 | 9.4 | 4.99 (4.08) | 9.3 | 2.0 | 4 | 1 | 2 | 3 | 1 | 2 | 13 | 9 (12) | E. faecium, unknown, E. coli, unknown, Candida tropicalis |
6 | 19.3 | 2.4 | 9.5 | 0.47 (0.01) | 8.2 | 4.1 | 3 | 3 | 2 | 4 | 3 | 2 | 17 | 10 (59) | Aeromonas hydrophila, Enterococcus faecalis |
7 | 17.1 | 3.9 | 10.9 | 0.14 (0.05) | 8.7 | 3.5 | 3 | 3 | 1 | 3 | 1 | 2 | 13 | 8 (20) | Unknown, E. faecalis |
8 | 17.4 | 3.2 | 10.3 | 1.75 (1.31) | 8.4 | 2.8 | 3 | 2 | 1 | 3 | 1 | 4 | 14 | None | Unknown, Acinetobacter baumannii, Staphylococcus aureus, C. glabrata |
9 | 18.8 | 3.7 | 8.0 | 1.82 (0.34) | 9.4 | 2.2 | 4 | 2 | 2 | 4 | 3 | 1 | 13 | None | C. glabrata |
10 | 23.8 | 3.0 | 12.8 | 1.16 (0.06) | 8.6 | 2.6 | 3 | 3 | 1 | 2 | 1 | 2 | 12 | 10 (12) | E. coli, E. faecium, IRAB |
11 | 15.2 | 2.8 | 7.8 | 0.36 (none) | 8.7 | 3.5 | 1 | 2 | 1 | 2 | 0 | 0 | 6 | 5 (107) | None |
12 | 18.4 | 2.4 | 10.8 | 4.06 (0.05) | 8.8 | 3.8 | 3 | 2 | 0 | 2 | 2 | 1 | 10 | 8 (10) | E. faecium |
13 | 19.1 | 3.4 | 9.9 | 1.03 (1.24) | 8.8 | 3.9 | 2 | 2 | 0 | 2 | 2 | 1 | 9 | 1 (29) | E. faecium, unknown, Coagulase(−)Staphylococcus, unknown |